Alcohol dependence is a devastating illness affecting a large population, and new pharmacological treatments with good efficacy are greatly needed. One potential candidate is varenicline, a smoking cessation agent with partial agonist action at α4 β2 nicotinic acetylcholine receptors
Rationale Emerging evidence suggests that the α4β2 form of the nicotinic acetylcholine receptor (nAC...
Varenicline (VAR) is a partial nicotinic receptor agonist that is an effective smoking cessation med...
Varenicline, a smoking-cessation agent, may be useful in treating alcohol use disorders. An importan...
AbstractThe pharmacotherapy currently used for alcohol dependence may reduce alcohol consumption and...
Background and Objectives: Alcohol and nicotine dependence are serious public health problems worldw...
Abstract Alcohol dependence is a disease that impacts millions of individuals worldwide. There has b...
Rationale \ud Emerging evidence suggests that the α4β2 form of the nicotinic acetylcholine receptor...
BACKGROUND: Alcohol and tobacco misuse and dependence are highly comorbid disorders. Varenicline all...
Rationale: Treatment of the most widely abused drugs, nicotine and alcohol, is hampered by high rate...
Varenicline was approved by the Foodand Drug Administration (FDA) as a prescription smoking cessatio...
Varenicline is used to treat tobacco dependence. While varenicline decreases craving during a quit ...
Purpose/Background: Varenicline has proven its efficacy in the treatment of nicotine dependence, an...
AbstractBackground: Smoking is the leading preventable risk to human health. Various agents have bee...
Jr, et al. A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylc...
Background: Preclinical and emerging clinical evidence indicates that varenicline, a nicotinic parti...
Rationale Emerging evidence suggests that the α4β2 form of the nicotinic acetylcholine receptor (nAC...
Varenicline (VAR) is a partial nicotinic receptor agonist that is an effective smoking cessation med...
Varenicline, a smoking-cessation agent, may be useful in treating alcohol use disorders. An importan...
AbstractThe pharmacotherapy currently used for alcohol dependence may reduce alcohol consumption and...
Background and Objectives: Alcohol and nicotine dependence are serious public health problems worldw...
Abstract Alcohol dependence is a disease that impacts millions of individuals worldwide. There has b...
Rationale \ud Emerging evidence suggests that the α4β2 form of the nicotinic acetylcholine receptor...
BACKGROUND: Alcohol and tobacco misuse and dependence are highly comorbid disorders. Varenicline all...
Rationale: Treatment of the most widely abused drugs, nicotine and alcohol, is hampered by high rate...
Varenicline was approved by the Foodand Drug Administration (FDA) as a prescription smoking cessatio...
Varenicline is used to treat tobacco dependence. While varenicline decreases craving during a quit ...
Purpose/Background: Varenicline has proven its efficacy in the treatment of nicotine dependence, an...
AbstractBackground: Smoking is the leading preventable risk to human health. Various agents have bee...
Jr, et al. A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylc...
Background: Preclinical and emerging clinical evidence indicates that varenicline, a nicotinic parti...
Rationale Emerging evidence suggests that the α4β2 form of the nicotinic acetylcholine receptor (nAC...
Varenicline (VAR) is a partial nicotinic receptor agonist that is an effective smoking cessation med...
Varenicline, a smoking-cessation agent, may be useful in treating alcohol use disorders. An importan...